My non-expert read would be good and bad. Hasn't knocked it out of the park by not meeting primary endpoint. Won't be able to go for immediate approval, but can discuss a pathway with FDA. BUT looks positive for having data to inform a confirmatory trial.
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-28
-
- There are more pages in this discussion • 995 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.003(0.22%) |
Mkt cap ! $1.295B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $4.888M | 4.303M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 108356 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 51870 | 35 |
View Market Depth
| Last trade - 13.03pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |